February 10, 2025- Duquesne University and CVS Pharmacy have introduced an innovative new education support program as part of their efforts to help address the national pharmacist shortage, especially in underrepresented areas, remove barriers to obtaining higher education and provide resources for affordable professional advancement. Through the Tuition Advantage … [Read more...]
BD Medication Management Technology ranked best in KLAS for sixth consecutive year
February 10, 2025- BD announced that for the sixth consecutive year, medication management technology from BD has been named Best in KLAS. The BD Pyxis™ MedStation ES was honored with the 2025 Best in KLAS award for Automated Dispensing Cabinets and the BD Alaris™ Infusion System was honored in the Smart Pumps – Traditional category. This recognition underscores BD’s market … [Read more...]
Abbott’s ‘Above the Bias’ Film reveals misconceptions can impact diabetes care
February 7, 2025- New survey results and a film released by Abbott highlight how everyday comments like these may affect people living with diabetes. People living with diabetes – which now includes 1 in 6 adults in America – face many barriers to receiving care. Survey data reveal that the misconceptions and stereotypes around the condition can weigh heavily on the minds of … [Read more...]
McKesson’s Board of Directors elects Lynne Doughtie and Julie Gerberding as new directors
February 7, 2025- McKesson Corporation announced that the McKesson board of directors has elected Lynne Doughtie and Dr. Julie Gerberding to join the board, effective February 3, 2025. Ms. Doughtie will serve on the Audit Committee and the Finance Committee, and Dr. Gerberding will serve on the Compliance Committee and the Compensation and Talent Committee. With these … [Read more...]
BD reports First Quarter Fiscal 2025 financial results
February 7, 2025- BD announced results for its fiscal 2025 first quarter which ended December 31, 2024. Recent highlights include that the company announced the BD board authorized the repurchase of up to 10 million shares of BD common stock in addition to the shares that remain available under the board's previous authorization in 2021. BD … [Read more...]
Thermo Fisher Scientific launches International CorEvitas Clinical Registry in Adolescent Alopecia Areata
February 7, 2025- Thermo Fisher Scientific Inc., announced the launch of the international CorEvitas Adolescent Alopecia Areata (AA) Registry, addressing a critical unmet need for real-world, adolescent-specific evidence and data related to this autoimmune disease, which causes patchy or complete hair loss on the scalp and other areas of the body. Data collected will enable … [Read more...]
Flu rates hit a second peak in the U.S. this season
February 7, 2024- For a second time this season, the flu is surging, with at least 41 states reporting high or very high levels of the virus, according to CBS News. Emergency room visits for the virus have shot up nearly 30% this week compared to the week before. Recent data from the CDC show there have been more than 20 million cases, 250,000 hospitalizations … [Read more...]
Humana Inc. releases annual Value-Based Care Report
February 7, 2025- Value-based care results in patients spending more time with their primary care clinician, less time in the hospital, and more frequent preventive care, based on research released by Humana Inc. in its annual Value-Based Care Report. The report’s data shows that Medicare Advantage (MA) patients receiving care under value-based arrangements saw fewer … [Read more...]
Making the grade
February 6, 2025- Yalda Jabbarpour, MD is a firm believer that primary care is not only essential to the health and well-being of every patient in the U.S., but it’s the backbone of the entire healthcare system. “Everyone in their lifetime will see a primary care clinician,” she said. Indeed, good primary care is essential for population and individual health, said Dr. … [Read more...]
McKesson Corporation reports Fiscal 2025 Third Quarter Results and raises full year adjusted EPS guidance
February 6, 2025- McKesson Corporation announced results for the third quarter ended December 31, 2024: Third Quarter Highlights: Fiscal 2025 Outlook: Continue Reading … [Read more...]